08/28/2025 07:00
Europa Worldwide Group Enhances Carbon Management and Reporting With Blue Yonder

The global regulatory landscape, particularly in the U.K. and European Union, acts as a powerful catalyst for change, urging companies to embrace sustainable practices that extend beyond basic compliance. Logistics service providers (LSPs) are witnessing an increased demand from their customers to actively monitor emissions and ensure adherence to both current and forthcoming regulations. That’s why Europa Worldwide Group, a leading LSP with a global presence, has adopted Blue Yonder’s Logistic...

09/22/2025 11:00
AB InBev and Netflix Announce Global Brand Partnership

AB InBev (Euronext: ABI) (NYSE: BUD) (MEXBOL: ANB) (JSE: ANH) and Netflix, Inc. (NASDAQ: NFLX) today announced a global partnership bringing together the world’s most iconic beer brands with one of the world’s most popular entertainment services. The partnership is unprecedented in the global reach and scale of activations across AB InBev’s portfolio of brands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922234597/en/ Both AB ...

09/19/2025 10:00
European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for BILDYOS® (denosumab) injection 60 mg/mL and BILPREVDA® (denosumab) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (denosumab), respectively, for all indications of the reference products.1,2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250919502394/en/ “The EC ...